Mupirox (Mupirocin)

Mupirocin, the active ingredient in Mupirox, is an antibiotic presented as a topical formulation for skin use. It treats bacterial skin infections such as impetigo, folliculitis and secondary infections in patients of all ages.

GNH USA supplies Mupirox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is applied topically to manage bacterial skin infections caused by susceptible organisms.

- Impetigo: reduces bacterial load and promotes healing of superficial lesions. - Folliculitis: eradicates Staphylococcus aureus causing inflamed hair follicles. - Secondary bacterial infection of eczema or dermatitis: controls infection and limits spread. - Infected minor cuts, abrasions or burns: prevents bacterial colonisation and supports tissue recovery.

Mupirocin is generally well tolerated, but local reactions may occur.

Common Side Effects: - Burning or stinging at the application site. - Itching or mild erythema. - Dryness or flaking of the treated skin. - Mild pain or discomfort.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or severe redness. - Anaphylactic reaction presenting with systemic symptoms. - Rare systemic effects such as neutropenia or Stevens‑Johnson syndrome. - Severe skin ulceration or necrosis. - Persistent infection despite therapy, indicating possible resistance.

Before using Mupirox, consider the following safety measures.

- Use only on intact skin: avoid eyes, mucous membranes and open wounds unless directed. - Do not apply to large body areas or extensive broken skin without medical supervision. - Avoid use in patients with known hypersensitivity to mupirocin or related compounds. - Pregnancy and breastfeeding: safety not established; consult a prescriber. - Keep out of reach of children: accidental ingestion may cause systemic effects. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Mupirox has limited systemic absorption, yet certain co‑applications merit attention.

Major Interactions (Avoid): - None identified: no major drug‑drug interactions reported for topical mupirocin.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: concurrent use may increase local irritation. - Topical corticosteroids: may mask infection signs, requiring close monitoring. - Alcohol‑based antiseptics: may enhance skin irritation when used together. - Systemic antibiotics: may reduce the need for topical therapy; assess clinical necessity. - Antifungal creams: simultaneous use may alter skin flora and affect tolerance.